Coriaria intermedia
Coriaria intermedia
Coriaria intermedia is an evergreen shrub native to New Zealand, Patagonia, and parts of Australia. While there are no traditional uses recorded for this plant, it has been the subject of scientific investigation. Seven bioactive compounds have been identified from Coriaria intermedia, with corilagin showing potential benefits in managing diabetes and inflammation. Additionally, a novel species of Streptomyces, named Streptomyces coriariae sp. nov., was isolated from root nodules of this plant, indicating its role in nitrogen fixation. The study also identified Frankia cluster-2 strains associated with Coriaria species, suggesting early divergence within these species and separate dispersal routes during the Gondwanan period. Currently, no major safety issues or drug interactions have been recorded for Coriaria intermedia.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Seven compounds from Coriaria intermedia were identified, with one (corilagin) showing potential for both diabetes and inflammation.
- Strain CMB-FB represents a novel species, Streptomyces coriariae sp. nov., isolated from Coriaria intermedia root nodules.
- The study identified novel Frankia cluster-2 strains associated with Coriaria species in New Zealand and Patagonia, suggesting early divergence of these species.
- The study found evidence of a clear split within Frankia cluster-2, suggesting divergence in Gondwana and separate dispersal routes.
Frequently asked questions
What is Coriaria intermedia?
Coriaria intermedia (Coriaria intermedia) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Coriaria intermedia?
4 sourced findings are recorded for Coriaria intermedia; the strongest carries evidence grade D. For example: Seven compounds from Coriaria intermedia were identified, with one (corilagin) showing potential for both diabetes and inflammation.
How strong is the evidence for Coriaria intermedia?
The strongest finding for Coriaria intermedia carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Coriaria intermedia safe? What are the side effects?
No major safety issues are recorded for Coriaria intermedia in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Coriaria intermedia interact with medications?
No drug interactions are recorded for Coriaria intermedia in our sources. This does not rule them out — check with a pharmacist.
Is Coriaria intermedia a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 A tale of two lineages: how the strains of the earliest divergent symbiotic Frankia clade spread over the world. literature abstract metadata
- T2 Streptomyces coriariae sp. nov., a novel streptomycete isolated from actinorhizal nodules of Coriaria intermedia. literature abstract metadata
- T2 Genome analysis and biogeographic distribution of the earliest divergent Frankia clade in the southern hemisphere. literature abstract metadata
- T2 Anti-diabetic and anti-inflammatory bioactive hits from Coriaria intermedia Matsum. stem and Dracontomelon dao (Blanco) Merr. & Rolfe bark through bioassay-guided fractionation and liquid chromatography-tandem mass spectrometry. literature abstract metadata